References
- Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268–279.
- Strathy JH, Molgaard CA, Coulam CB, et al. Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril. 1982;38(6):667–672.
- Vercellini P, Vigano P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275.
- Halme J, Hammond MG, Hulka JF, et al. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol. 1984;64(2):151–154.
- Augoulea A, Mastorakos G, Lambrinoudaki I, et al. The role of the oxidative-stress in the endometriosis-related infertility. Gynecol Endocrinol. 2009;25(2):75–81.
- Christodoulakos G, Augoulea A, Lambrinoudaki I, et al. Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’. Eur J Contracept Reprod Health Care. 2007;12(3):194–202.
- Gupta S, Ghulmiyyah J, Sharma R, et al. Power of proteomics in linking oxidative stress and female infertility. Biomed Res Int. 2014;2014:916212.
- Matsuzaki S, Schubert B. Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril. 2010;93(7):2431–2432.
- Polak G, Wertel I, Barczyński B, et al. Increased levels of oxidative stress markers in the peritoneal fluid of women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2013;168(2):187–190.
- Sharma I, Dhaliwal LK, Saha SC, et al. Role of 8-iso-prostaglandin F2alpha and 25-hydroxycholesterol in the pathophysiology of endometriosis. Fertil Steril. 2010;94(1):63–70.
- Verit FF, Erel O, Celik N. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Hum Reprod. 2007;23(1):100–104.
- Nassif J, Abbasi SA, Nassar A, et al. The role of NADPH-derived reactive oxygen species production in the pathogenesis of endometriosis: a novel mechanistic approach. J Biol Regul Homeost Agents. 2016;30(1):31–40.
- Rhee SG, Kang SW, Chang TS, et al. Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 2001;52(1–2):35–41.
- Wood ZA, Schroder E, Robin Harris J, et al. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci. 2003;28(1):32–40.
- Schulte J, Struck J, Bergmann A, et al. Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum. Clin Chim Acta. 2010;411(17–18):1258–1263.
- Wang X, Wang L, Wang X, et al. Structural insights into the peroxidase activity and inactivation of human peroxiredoxin 4. Biochem J. 2012;441(1):113–118.
- Yan Y, Wladyka C, Fujii J, et al. Prdx4 is a compartment-specific H2O2 sensor that regulates neurogenesis by controlling surface expression of GDE2. Nat Commun. 2015;6:7006.
- Basu A, Banerjee H, Rojas H, et al. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate. 2011;71(7):755–765.
- Chen G, Gharib TG, Huang CC, et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res. 2002;8(7):2298–2305.
- Chen JH, Ni RZ, Xiao MB, et al. Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue. Hepatobil Pancr Dis Int. 2009;8(2):193–200.
- Jiang H, Wu L, Mishra M, et al. Expression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy. Am J Cancer Res. 2014;4(5):445–460.
- Zhang B, Wang Y, Su Y. Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett. 2009;286(2):154–160.
- Wang W, Shen XB, Huang DB, et al. Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway. Cell Oncol. 2019;42(6):769–781.
- Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update. 2014;20(3):386–402.
- Jin DY, Chae HZ, Rhee SG, et al. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem. 1997;272(49):30952–30961.
- Wan L, Zou Y, Wan LH, et al. Tanshinone IIA inhibits the proliferation, migration and invasion of ectopic endometrial stromal cells of adenomyosis via 14-3-3ζ downregulation. Arch Gynecol Obstet. 2015;292(6):1301–1309.
- Zou Y, Liu FY, Wang LQ, et al. Downregulation of DNA methyltransferase 3 alpha promotes cell proliferation and invasion of ectopic endometrial stromal cells in adenomyosis. Gene. 2017;604:41–47.
- Kim TH, Song J, Alcantara Llaguno SR, et al. Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth. PLoS One. 2012;7(8):e42818.
- Rao Z, Wang S, Wang J. Peroxiredoxin 4 inhibits IL-1β-induced chondrocyte apoptosis via PI3K/AKT signaling . Biomed Pharmacother. 2017;90:414–420.
- Guo X, Noguchi H, Ishii N, et al. The association of peroxiredoxin 4 with the initiation and progression of hepatocellular carcinoma. Antioxid Redox Signal. 2019;30(10):1271–1284.
- Starzinski-Powitz A, Handrow-Metzmacher H, Kotzian S. The putative role of cell adhesion molecules in endometriosis: can we learn from tumour metastasis? Mol Med Today. 1999;5(7):304–309.
- Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J Soc Gynecol Investig. 2006;13(7):467–476.
- Zafrakas M, Tarlatzis BC, Streichert T, et al. Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potential. Int J Mol Med. 2008;21(3):335–344.
- Deevey S. Endometriosis: internet resources. Med Ref Serv Q. 2005;24(1):67–76.
- Vigano P, Parazzini F, Somigliana E, et al. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):177–200.
- Beliard A, Noel A, Foidart JM. Reduction of apoptosis and proliferation in endometriosis. Fertil Steril. 2004;82(1):80–85.
- Zhao Q, Ye M, Yang W, et al. Effect of Mst1 on endometriosis apoptosis and migration: role of Drp1-related mitochondrial fission and Parkin-required mitophagy. Cell Physiol Biochem. 2018;45(3):1172–1190.